Skip to main content
. 2016 Jan 8;15:3. doi: 10.1186/s12939-015-0288-2

Table 2.

Hazard ratio for all-cause mortality among patients with newly diagnosed hypertension

Unadjusted Adjusted
Characteristics HR 95% CI HR 95% CI
Age
 20 ~ 49 1.00 1.00
 50 ~ 59 1.88 (1.65–2.15) 2.35 (2.06–2.68)
 60 ~ 69 4.41 (3.93–4.96) 4.85 (4.31–5.46)
 ≥70 15.49 (13.87–17.30) 12.60 (11.26–14.11)
Sex
 Male 1.10 (1.05–1.15) 1.56 (1.49–1.63)
 Female 1.00 1.00
Health insurance type
 National health insurance 1.00 1.00
 Medical aid 1.58 (1.40–1.79) 0.80 (0.70–0.91)
Income, N (%)
 Low (≤20th percentile) 1.27 (1.19–1.35) 1.25 (1.17–1.34)
 Middle (21st–80th percentile) 0.95 (0.90–1.00) 1.16 (1.10–1.22)
 High (≥81st percentile) 1.00 1.00
Carstairs index, N (%)
 Disadvantaged neighborhood (below median) 1.03 (0.95–1.10) 1.08 (1.02–1.15)
 Advantaged neighborhood (above median) 1.00 1.00
Residential area
 Metropolitan 1.00 1.00
 Urban 1.11 (1.06–1.17) 1.04 (0.98–1.11)
 Rural 1.47 (1.38–1.57) 1.14 (1.05–1.24)
Charlson comorbidity indexa
 0–1 1.00 1.00
 2 1.46 (1.37–1.55) 1.25 (1.18–1.34)
 3 2.15 (2.01–2.30) 1.67 (1.56–1.79)
 ≥4 4.41 (4.17–4.66) 2.69 (2.54–2.85)
Number of risk factors
 None 1.00 1.00
 with diabetes or dyslipidemia 0.57 (0.54–0.60) 0.63 (0.60–0.66)
 with diabetes and dyslipidemia 0.26 (0.23–0.29) 0.36 (0.33–0.40)
 Disability
 Normal 1.00 1.00
 Mild disability 1.47 (1.36–1.59) 1.11 (1.03–1.21)
 Severe disability 3.00 (2.77–3.27) 1.44 (1.33–1.57)
Health screening during follow-up period
 1 1.00 1.00
 2 0.31 (0.29–0.34) 0.39 (0.36–0.42)
 ≥3 0.11 (0.10–0.12) 0.17 (0.16–0.19)

acalculated by extracting diabetes, hypertension, and hyperlipidemia from among comorbidity components